Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hunan Nucien Pharmaceutical Co (688189) Fair Value & Analysis

Healthcare · CN · Market cap 1.6B CNY

Price¥6.10
Fair Value¥1.38
Upside-77.4%
Quality82/100
Evidence: Medium Range ¥0.9200 – ¥1.85

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Hunan Nucien Pharmaceutical Co (688189) currently trades at ¥6.10, while our model-based Fair Value estimate is ¥1.38 — implying the stock looks roughly 77.4% overvalued today. We read business quality at 82/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Hunan Nucien Pharmaceutical Co (688189) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥1.38 versus a price of ¥6.10 — about −77% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 688189?
Our 21-model fair value for Hunan Nucien Pharmaceutical Co is ¥1.38 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥6.10.
What is the quality score of 688189?
Hunan Nucien Pharmaceutical Co has a Quality Score of 82/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.